Physician profile
Jack R Inge
NPI 1992796361
$156,846.53
in general payments reported to CMS, 2019-2025
47 companies · $67K in 2025
The $67K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $2,645 · 2021: $21K · 2022: $18K · 2023: $19K · 2024: $18K · 2025: $67K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $89K · Food and Beverage: $6,639 · Travel and Lodging: $4,080 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $89,170.04 |
| Food and Beverage | $6,638.80 |
| Travel and Lodging | $4,080.12 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $151,190.99 | 2019-2025 | Da Vinci Surgical System |
| Abbvie INC. | $715.22 | 2019-2025 | |
| Astellas Pharma US INC | $592.87 | 2019-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $429.56 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $363.33 | 2021-2025 | |
| Coopersurgical, INC. | $353.12 | 2019-2024 | Paragard T 380a, Endosee |
| Pfizer INC. | $237.00 | 2021-2025 | |
| Novo Nordisk INC | $235.04 | 2023-2025 | Wegovy |
| Therapeuticsmd, INC. | $229.03 | 2019-2022 | |
| Organon LLC | $215.33 | 2022-2025 | Nexplanon, Jada System |
| Evofem Biosciences, INC. | $208.36 | 2021-2025 | Phexxi, Solosec, Phexx |
| Baxter Healthcare | $193.36 | 2020 | |
| Hologic Sales and Service, LLC | $176.03 | 2021-2024 | Acessa Provu System, Myosure Tissue Removal Device, Novasure |
| Ethicon US, LLC | $144.67 | 2025 | Prolene |
| Biogen, INC. | $134.31 | 2024-2025 | Zurzuvae |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $124.99 | 2024 | Airseal |
| Agile Therapeutics, INC. | $112.73 | 2022-2024 | Twirla |
| Daiichi Sankyo INC. | $110.06 | 2019-2022 | |
| Myovant Sciences INC. | $101.85 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $80.04 | 2023-2025 | Myfembree, Gemtesa |
| Duchesnay USA Incorporated | $72.76 | 2019 | |
| Mylan Pharmaceuticals INC. | $62.64 | 2019-2021 | |
| Shield Therapeutics INC | $58.78 | 2024 | |
| Lilly USA, LLC | $54.00 | 2023-2025 | Zepbound |
| Merck Sharp & Dohme LLC | $53.07 | 2019-2021 | |
| Zyla Life Sciences, INC. | $52.05 | 2019-2020 | |
| Exact Sciences Corporation | $47.71 | 2023-2024 | Cologuard Collection Kit |
| Medtronic, INC. | $45.13 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $44.23 | 2021 | |
| Boston Scientific Corporation | $42.80 | 2025 | Bulkamid |
| Biohaven Pharmaceutical Holding Company Ltd. | $36.87 | 2022 | |
| Sage Therapeutics, LLC | $36.76 | 2021-2022 | |
| Avion Pharmaceuticals | $35.25 | 2021-2022 | |
| Exeltis, USA INC. | $34.00 | 2025 | Slynd |
| Lupin INC. | $26.56 | 2020 | |
| Dexcom, INC. | $24.81 | 2025 | Dexcom G6 Transmitter |
| Agios Pharmaceuticals, INC. | $22.31 | 2023 | Pyrukynd |
| Scynexis, INC. | $21.51 | 2022 | |
| Abbott Laboratories | $21.04 | 2024 | Freestyle Libre 3 |
| Covidien Lp | $18.24 | 2020 | |
| Millicent US INC | $17.75 | 2024 | Femring, Intrarosa |
| Trevena, INC. | $16.92 | 2021 | |
| Terumo Medical Corporation | $15.83 | 2021 | |
| Medicem INC. | $13.76 | 2021 | |
| Amgen INC. | $13.05 | 2020 | |
| Meditrina | $10.81 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Inge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.